About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
DELIVERABLE VOLUME
Deliverable
Volume
Mankind Pharma Ltd.
BSE Code
543904
ISIN Demat
INE634S01028
Book Value
386.60
NSE Code
MANKIND
Dividend Yield %
0.00
Market Cap
834016.43
P/E
48.96
EPS
41.27
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2026
2025
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2026
2025
Date
Total Volume
Deliverable Volume
Deliverable Volume [%]
24-Mar-2026
22875
13480
58.93
23-Mar-2026
14922
6539
43.82
20-Mar-2026
80243
66282
82.60
19-Mar-2026
15863
7552
47.61
18-Mar-2026
5638
2930
51.97
17-Mar-2026
81271
70482
86.72
16-Mar-2026
9917
5163
52.06
13-Mar-2026
19250
9896
51.41
12-Mar-2026
3604
1452
40.29
11-Mar-2026
15134
9481
62.65
10-Mar-2026
18499
5578
30.15
09-Mar-2026
29131
8136
27.93
06-Mar-2026
7592
3113
41.00
05-Mar-2026
6161
2650
43.01
04-Mar-2026
7387
3809
51.56
02-Mar-2026
39732
21813
54.90
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.